While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive...

The Centers for Disease Control and Prevention (CDC) will be awarding this week more than $12 million to 23 states and the District of Columbia to support their responses to the opioid overdose epidemic....

More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a new report released today by the Centers for Disease Control and Prevention (CDC). The report finds that...

The use of acupuncture to treat pain dates back to the earliest recorded history in China. Despite centuries of acupuncture, it’s still not clear why this method of applying and stimulating tiny needles...

Researchers have identified mutations in a gene called CARD11 that lead to atopic dermatitis, or eczema, an allergic skin disease. Scientists from the National Institute of Allergy and Infectious Diseases...

Researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a new surgical tool that uses low-frequency intravascular ultrasound to break down blood...

The metropolitan Cleveland, OH area saw 41 fatalities due to heroin/fentanyl  in May 2017, according to the Cuyahoga Medical Examiner Friday. Eighteen of the deaths were in the city of Cleveland, while...

The Georgia Department of Public Health (DPH) has become aware of a dangerous, potentially lethal substance contained in street drugs surfacing in central and South Georgia. Dozens of patients have been...

Results of a definitive clinical trial show that a new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels. Results show that the total rate of clinical...

In April, Canadian Prime Minister Justin Trudeau’s government introduced legislation that would allow adults to possess, share and purchase marijuana, while also strengthening penalties for those...